Jing Hao

Impact of anticancer drugs price cut on physician's prescription choices on first-line chemotherapy regimens and health expenditure for advanced non-small cell lung cancer in China.

Bei Li, Meiying Li, Luan-Luan Sun, 2016, Journal of thoracic disease.

Lung cancer combination therapy: co-delivery of paclitaxel and doxorubicin by nanostructured lipid carriers for synergistic effect

Bei Li, Xiuwen Wang, Ya-wei Wang, 2016, Drug delivery.

Efficacy and safety of apatinib in advanced refractory soft tissue sarcoma and association with histologic subtypes: a multicenter retrospective study

C. Li, J. Wang, Qiang Zhang, 2022, Annals of translational medicine.

Unique metastasis‐associated lncRNA signature optimizes prediction of tumor relapse in lung adenocarcinoma

L. Du, G. Zheng, Lili Wang, 2020, Thoracic cancer.

Anaplastic lymphoma kinase fusion protein expression is associated with a favorable prognosis in resected invasive mucinous lung adenocarcinoma: A retrospective study from two Chinese tertiary hospitals

Peng Su, Haiyan Jing, Jing Liu, 2022, Journal of cancer research and therapeutics.

Could S-1-based non-platinum doublet chemotherapy be a new option as a second-line treatment for advanced non-small cell lung cancer patients? A multicenter retrospective study

J. Liu, C. Yi, Fei Ding, 2023, Frontiers in Oncology.

Correlation between RAGE gene promoter methylation and diabetic retinal inflammation

Shifeng Kan, Zhen Wu, Jing Hao, 2017, Experimental and therapeutic medicine.